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Loss of Pax6 Causes Regional
Changes in Dll1 Expression in
Developing Cerebral Cortex
Elena Dorà†, David J. Price and John O. Mason*
Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom
The transcription factor Pax6 controls multiple aspects of forebrain development.
Conditional deletion of Pax6 in embryonic mouse cortex causes increased proliferation
of cortical progenitor cells and a concomitant decrease in neural differentiation. Notch
signaling regulates the balance between proliferation and differentiation of cortical
progenitor cells, suggesting a possible connection between Pax6 and Notch signaling.
We investigated how expression of the Notch ligand delta-like 1 (Dll1) is altered by loss
of Pax6. Acute cortex-specific deletion of Pax6 resulted in a widespread decrease in the
density of Dll1+ cells at embryonic days 12.5 and 13.5 (E12.5 and E13.5). In constitutive
loss-of-function mutants, decreases in the densities of Dll1+ cells were more limited both
spatially and temporally. Controlled over-expression of Pax6 had no detectable effect
on Dll1 expression. The proneural transcription factor Neurog2 is a target of Pax6 that
can activate Dll1 expression and we found clear co-expression of Neurog2 and Dll1 in
radial glial progenitors, suggesting that Pax6’s effect on Dll1 could be mediated through
Neurog2. However, we found no change in Dll1+ cells in Neurog2−/− cortex suggesting
either that Neurog2 is not directly involved, or that its loss of function in embryonic cortex
can be compensated for.
Keywords: Pax6, cortical development, progenitor cells, delta-like 1, Notch pathway
INTRODUCTION
As the brain develops during embryogenesis it must ensure that appropriate numbers of cells
are born at the appropriate time, such that each region of the brain reaches the correct final size.
To achieve this, the relative rates of proliferation and differentiation of neural progenitor cells
must be tightly controlled. The earliest progenitor cells in the embryonic cortex, neuroepithelial
cells, divide symmetrically to generate two new progenitors, expanding the progenitor pool. As
development proceeds, neuroepithelial progenitors transform into radial glia cells (RGCs),
a major class of neural progenitors. RGCs may divide symmetrically to give rise to two
identical progenitor cell daughters, or asymmetrically, giving rise to one radial glial cell and
one more differentiated cell—either a neuron, or an intermediate progenitor cell (IPC). In the
mouse, most IPCs divide symmetrically to produce two neurons, but a small proportion divide
asymmetrically to give rise to one progenitor and one neuron (Haubensak et al., 2004; Noctor
et al., 2004; Pontious et al., 2008). Clearly, RGCs must carefully balance their output between
neurogenic cells (IPCs and neurons) and new RGC progenitors. If too many neurogenic cells
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are produced early, this would lead to a reduction in progenitor
numbers and an overall smaller cortex. Conversely, too few
neurogenic divisions would increase progenitor numbers and
cortical size.
The transcription factor Pax6 is a key regulator of forebrain
development, with diverse roles in corticogenesis, including
control of cortical cell number (reviewed by Manuel et al.,
2015; Ypsilanti and Rubenstein, 2016). Pax6 is expressed
highly in RGCs, but its levels decrease in IPCs (Elsen et al.,
2018). We recently showed that acute deletion of Pax6 in
the embryonic cortex leads to both an increase in cortical
progenitor proliferation and a decrease in neural differentiation
(Quintana-Urzainqui et al., 2018). This suggests that Pax6 can
regulate the output from cortical RGCs by influencing the
balance between their proliferation and differentiation. As a
transcription factor, Pax6’s effects on RGC output are most
likely exerted through control of target gene expression. Many
Pax6 regulated genes have been identified (Sansom et al., 2009;
Wolf et al., 2009; Mi et al., 2013; Xie et al., 2013; Sun et al., 2015;
Quintana-Urzainqui et al., 2018) including the pro-neurogenic
transcription factor Neurog2 (previously known as Ngn2), which
is directly regulated by Pax6 (Scardigli et al., 2003). In addition
to its pro-neurogenic activity, Neurog2 activates expression of
the Notch ligand Delta-like 1 (Dll1; Castro et al., 2006; Shimojo
et al., 2008). Notch signaling is a well-characterized regulator of
neural progenitor maintenance and differentiation. When Notch
signaling is active, the Notch ligands Dll1 and Jagged engage
Notch receptors on the surface of neighboring cells and induce
expression of genes that inhibit neural differentiation, thereby
maintaining the cell in a proliferative state (Pierfelice et al., 2011).
Taken together, this suggests a plausible hypothesis to explain
how Pax6 could influence behavior of the RGC progenitor
pool in embryonic cortex. Pax6 activates Neurog2 expression
in RGCs, in turn Neurog2 acts both to promote a pro-neural
fate in cells expressing it and to drive expression of Dll1, which
could then feed back to neighboring cells to promote their
proliferation and thereby reduce their likelihood of becoming
pro-neurogenic. Consistent with this idea, microarray and
transcriptome sequencing studies have shown that overall levels
of Dll1 expression are significantly decreased in Pax6−/− mutant
cortex (Mi et al., 2013; Quintana-Urzainqui et al., 2018) and
increased in transgenic mice that overexpress Pax6 (Sansom
et al., 2009), but it is not known how the cellular pattern of Dll1
expression is affected in the absence of Pax6. Pax6 is expressed
in a gradient across the developing cortex and some of its
effects on cell cycle have been shown to be confined to regions
where Pax6 expression is highest (Mi et al., 2013). It is therefore
important to examine the spatial effects of Pax6 loss on Dll1
expression in more detail.
In the present study, we investigated how the spatial
distribution of Dll1-expressing cells is affected by loss of Pax6.
We found significantly reduced densities of Dll1-expressing
cells in areas of the embryonic cortex in both constitutive
and conditional Pax6 mutants, consistent with the suggestion
that Pax6 promotes Dll1 expression. Interestingly, the effect
on Dll1 expression was greater in conditional Pax6 mutants
than in Pax6−/− null mutants of the same age, suggesting the
presence of a compensatory mechanism which has not had time
to take effect in the conditional mutants. We also found that
many RGCs co-expressed Neurog2 and Dll1, as predicted by
our hypothesis. However, while loss of Pax6 led to a dramatic
decrease in Neurog2 expression, its effect on Dll1 expression
was less pronounced and Dll1 expression was unaffected in
Neurog2−/− mutant cortex, suggesting that additional levels of
control of Dll1 expression are present.
MATERIALS AND METHODS
Mice
All animal experiments were conducted in accordance with
the guidelines of the UK Animals (Scientific Procedures) Act
1986 and were approved by Edinburgh University’s Animal
Ethics Committee. For all crosses, the morning on which
the vaginal plug appeared was deemed embryonic day 0.5
(E0.5). Pax6−/− embryos were obtained by crossing Pax6Sey/+
heterozygotes (Hill et al., 1991) and non-homozygous littermates
were used as controls. Pax6 cortex-specific conditional mutant
embryos (Emx1cre-ERT2;Pax6loxP/loxP, abbreviated to cKO) were
obtained as described previously (Mi et al., 2013). Cre activity
was induced by administering 10 mg of tamoxifen (Sigma)
by oral gavage at E9.5. PAX77 mice (Schedl et al., 1996)
carry a yeast artificial chromosome transgene containing
multiple copies of human PAX6 under the control of
its own regulatory elements and express PAX6 protein at
approximately three-fold of normal levels (Manuel et al., 2007).
Neurog2−/− embryos were obtained by crossing Neurog2cre/+
heterozygotes in which insertion of cre coding sequence
creates a null allele of Neurog2 (Zirlinger et al., 2002).
Embryos were dissected in cold phosphate buffered saline
(PBS), fixed overnight in 4% paraformaldehyde at 4◦C,
cryo-protected overnight in 30% sucrose at 4◦C, snap frozen
in 50:50, OCT: 30% sucrose mix and cryosectioned at a
thickness of 10 µm.
In situHybridization/Immunohistochemistry
In situ hybridization was performed as previously described
(Yu et al., 2009). The Dll1 riboprobe (Ramos et al., 2010) was
labeled with digoxigenin for both chromogenic and fluorescent
in situ hybridizations. The Neurog2 riboprobe (Gradwohl et al.,
1996) was labeled with dinitrophenol for fluorescent in situ
hybridizations. For double in situ hybridization, probes were
detected sequentially and slides were incubated in 10 mM HCl
prior to detection of the second probe.
For immunohistochemistry subsequent to fluorescent in situ
hybridization, antigen retrieval was carried out in 10 mM citrate
buffer pH 6.0 in a 90◦C water bath for 40 min. The primary
antibody was rabbit anti-Tbr2 (1:100; Abcam Ab23345) and the
secondary antibody was goat anti-rabbit IgG Alexa Fluorr 488
(1:400; Abcam). Nuclei were counterstained with DAPI (Thermo
Fisher Scientific, Waltham, MA, USA).
Cell Counting
The density of Dll1-expressing cells and total cell density were
quantified using images produced from in situ hybridization and
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FIGURE 1 | Expression of delta-like 1 (Dll1) in Pax6−/− and control forebrain between E11.5 and E13.5. In situ hybridization showing Dll1 expression in Pax6−/−
mutant and control forebrains at E11.5 (A–D), E12.5 (E–P) and E13.5 (Q–T). At E11.5, the diencephalon in Pax6−/− mutants has a more open structure than in
controls (Caballero et al., 2014) and the dorsal telencephalon is smaller, leading to the altered appearance of the section in (B). Scale bars two leftmost
columns = 200 µm. Scale bars in rightmost columns = 20 µm. Abbreviations: Ctx, cortex; GE, ganglionic eminence; DI, diencephalon. Boxes in (C,D) indicate
representative areas used for counting Dll1+ cells.
H&E staining experiments. Sample areas were defined at rostral,
central and caudal regions of the cortex and cells were counted
in both medial and lateral areas of the cortex at each region
(Figure 2A schematic). Three sections per region, per embryo
were analyzed for each mutant and the appropriate control
littermate. Three embryos of each genotype and developmental
stage were analyzed, except for analysis of Dll1+ cell density in
PAX77 embryos at E12.5 where five embryos were used.
The width of the cortex at each area counted was measured
and a square was drawn on the tissue with each side equating
to the recorded width, to create the sample area for counting.
The total number of cells within each sample area was counted
then divided by the area to give the cell density, expressed as
number of cells per 0.01 mm2. The average cell density for each
region was calculated and statistical analysis by two or three-way
analyses of variance (ANOVA) and Tukey’s multiple comparison
test was conducted.
Cell count analysis was carried out using ImageJ software and
statistical analysis was carried out using Prism 6 software.
RESULTS
Expression of Dll1 in Pax6−/− Mutant
Embryonic Cortex
Previous analysis of the cortical transcriptome of Pax6−/−
mutant embryos revealed that overall Dll1 expression is reduced
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compared to controls (Sansom et al., 2009). To determine how
absence of Pax6 affects Dll1 expression in the embryonic cortex
in more detail, we carried out in situ hybridization for Dll1
on Pax6−/− mutant and control embryos between E11.5 and
13.5 (Figure 1). In controls, Dll1 was expressed in a salt and
pepper pattern throughout the telencephalic tissue at E11.5,
E12.5 and E13.5, in agreement with previous studies (Lindsell
et al., 1996; Kageyama et al., 2008; Kawaguchi et al., 2008;
Shimojo et al., 2008; Yoon et al., 2008). The distinctive salt
and pepper pattern is a consequence of periodic oscillations
in Dll1 mRNA levels, as found for a number of Notch
pathway components (Shimojo et al., 2016). Pax6−/− embryos
showed a similar salt-and-pepper pattern of Dll1 expression
at all three ages (Figure 1). The density of Pax6-expressing
cells appeared lower in some mutant sections (e.g., compare
panels Figures 1D,L,P to Figures 1C,K,O). To test whether
Dll1 expression was altered in the Pax6 mutant embryos, we
systematically counted the density of Dll1-expressing cells in
age-matched mutant and control embryos. Pax6 is expressed in
a gradient across the cortex (rostrolateral high to caudomedial
low) so, to test for possible differential effects caused by
differing levels of Pax6 expression, we calculated the density
of Dll1-expressing cells in both medial and lateral areas of
sections taken from rostral, central and caudal levels of Pax6−/−
and control cortex at E11.5, 12.5 and 13.5 (Figure 2). At
E11.5, the density of Dll1-expressing cells appeared consistently
higher in lateral regions of the cortex than in equivalent medial
regions, both in control and Pax6−/− embryos (Figure 2A).
Two-way ANOVA analysis confirmed a significant effect
of region (p < 0.001) and post hoc analysis by Tukey’s
multiple comparison test showed a significantly lower density
of Dll1-expressing cells in medial than lateral cortex at rostral
(p = 0.003), central (p = 0.015) and caudal (p = 0.03) levels
in control embryos. A similar pattern was found in Pax6−/−
mutants and ANOVA showed that there were no significant
differences between mutant and control cortices in any of the six
counted areas.
At E12.5, ANOVA showed that there were no significant
regional differences in the density of Dll1-expressing cells,
either in controls or Pax6−/− mutants (Figure 2B), indicating
that the medial—lateral difference observed at E11.5 has
disappeared by E12.5. Dll1-expressing cell density was lower
in all regions of Pax6−/− cortex compared to controls
(Figure 2B) and ANOVA indicated a significant effect
of genotype (p < 0.001). Post hoc analysis (using Tukey’s
multiple comparison test) confirmed significant decreases in
the density of Dll1-expressing cells in Pax6−/− mutants in both
centrolateral and caudomedial cortex (p = 0.028 and < 0.0001,
respectively), but the decreases in other regions were
not significant.
At E13.5, two-way ANOVA showed significant effects of both
region and genotype (both p < 0.001). In control embryos,
Dll1-expressing cell density was highest in caudomedial cortex
and post hoc analysis (Tukey) showed that Dll1-expressing cell
density in caudomedial cortex was significantly higher than in
rostrolateral (p = 0.0006) and centrolateral cortex (p < 0.0001)
but differences to other regions were not significant (Figure 2C).
FIGURE 2 | Quantitation of Dll1+ cells in Pax6−/− mutant and control cortex
at E11.5, E12.5 and E13.5. Bar graphs showing the density of
Dll1-expressing cells in specific regions of the cortex in Pax6−/− mutant and
control embryos at E11.5 (A) E12.5 (B) and E13.5 (C). The schematic
diagram in the top right corner indicates approximate positions from which
samples were taken for counting. Shading on the left hemisphere indicates
the gradient of Pax6 expression. N = 3 embryos of each genotype at each
age. ∗p < 0.05, Tukey’s multiple comparison test.
Post hoc analysis revealed that these regional differences were not
present in Pax6−/− mutants (Figure 2C). We found a significant
decrease in Dll1-expressing cell density in caudomedial cortex
of Pax6−/− mutants when compared to the same region in
controls (p = 0.012), but there was no significant difference
between mutant and control embryos in any of the other regions
tested (Figure 2C).
We found no significant differences in the overall
cell density between control and mutant cortex at E11.5
(82.3± 6.8 vs. 89.7± 15.2 cells/0.01 mm2), E12.5 (101.3± 4.4 vs.
101 ± 8.8 cells/0.01 mm2) or E13.5 (111 ± 6.3 vs.
108 ± 8.1 cells/0.01 mm2). This indicates that the observed
differences in the density of Dll1-expressing cells in Pax6−/−
cortex are due to changes in the number of Dll1-expressing cells,
and not simply a consequence of a lower total number of cells in
Pax6−/− mutants.
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These findings suggest that Pax6 loss lowers the proportions
of Dll1-expression produced in caudomedial regions but leaves
open the possibility that it also affects production in other
area. To examine this further, we switched from constitutive to
conditional mutants.
Conditional Mutation of Pax6 Causes a
Widespread Decrease in Dll1 Expression
As Pax6 is expressed throughout cortical development, from
around E8.5, it is possible that our results on the changes
in Dll1 expression in Pax6−/− embryos are complicated
by the effects of indirect, downstream consequences of the
absence of Pax6 activity at earlier stages, including the
possibility of compensatory adaptations. We therefore tested
the effects of acute, conditional deletion of Pax6 on cortical
expression of Dll1. Inducible loss of Pax6 was achieved by
combining a tamoxifen-inducible Emx1-creERT2 transgene that
is expressed specifically in cortex (Kessaris et al., 2006) with
a conditional (floxed) allele of Pax6 (Simpson et al., 2009).
The genotype of the experimental animals was Emx1CreErT2;
Pax6loxP/loxP (referred to as cKO) and heterozygous littermates
(i.e., Emx1CreErT2;Pax6loxP/+) were used as controls. Our
previous work with this strain showed that Pax6 protein is still
present at E11.5 when tamoxifen is administered at E9.5 (Mi
et al., 2013), so we confined our analysis of the cKO strain
to E12.5 and E13.5. Both cKO and control mutant embryos
expressed Dll1 in a distinctive salt and pepper pattern at
E12.5 and E13.5, similar to that seen in control and Pax6−/−
embryos (Figure 3).
Quantitation revealed a lower mean density of Dll1-
expressing cells across E12.5 cKO mutant cortex compared to
controls (Figure 4A). Two-way ANOVA showed a significant
effect of genotype (p < 0.0001) and post hoc analysis by Tukey’s
multiple comparison test confirmed significant decreases in
Dll1-expressing cell density in cKO cortex at rostromedial
(p = 0.003), rostrolateral (p = 0.01), centromedial (p = 0.002) and
caudomedial (p = 0.005) levels. Dll1+ cell density was also lower
in centrolateral and caudolateral cKO cortex, but the differences
were not significant (p = 0.08, p = 0.99 respectively). Thus,
conditional inactivation of Pax6 caused a widespread significant
reduction in the density of Dll1-expressing cells in E12.5 cortex.
At E13.5, the mean densities of Dll1-expressing cell were
lower in cKO cortex than in control embryos (Figure 4B).
Two-way ANOVA confirmed a significant effect of genotype
(p < 0.0001) but post hoc analysis (Tukey) indicated that
only the caudomedial region of cKO mutant cortex showed a
significant reduction in Dll1 expression at this stage (p = 0.012).
Overall, conditional mutagenesis had a greater and more
widespread effect than constitutive Pax6 loss, suggesting that
Pax6 is required during corticogenesis for the production of
a normal complement of Dll1-expressing cells across cortical
regions irrespective of the regional variation in normal levels
of Pax6 expression.
Overexpression of Pax6 Has No Effect on
Density of Dll1-Expressing Cells
To further test whether the production of Dll1-expressing cells is
sensitive to the level of Pax6 expression, we examined embryos
FIGURE 3 | Expression of Dll1 in Pax6 cKO mutant forebrain at E12.5. In situ hybridization showing Dll1 gene expression in rostral (A–D), central (E–H) and caudal
(I–L) regions of E12.5 Pax6 conditional mutant and control embryonic forebrains. Panels (C,G,K) show higher power images of regions shown in (A,E,I) and panels
(D,H,L) show higher power images of regions in (B,F,J). Scale bars in (A,B,E,F,I,J) = 200 µm; (C,D,G,H,K,L) = 20 µm. Pax6cKO = Emx1-CreERT2;Pax6loxP/loxP;
control = Emx1-CreERT2;Pax6loxP/+. Abbreviations: Ctx, cortex; GE, ganglionic eminence, DI, diencephalon. Boxes in (C,D) indicate representative areas used for
counting Dll1+ cells.
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FIGURE 4 | Quantitation of Dll1+ cells in Pax6 cKO and control forebrain at
E12.5 and E13.5. Bar graphs comparing the density of Dll1-expressing cells
in specific regions of the cortex in Pax6 cKO mutant and control embryos at
E12.5 (A) and E13.5 (B). N = 3 embryos of each genotype at each age.
∗p < 0.05, Tukey’s multiple comparison test.
from the PAX77 transgenic mouse strain, which expresses up to
three-fold higher levels of PAX6 protein (Manuel et al., 2007).
No obvious effect of position or genotype on Dll1 expression was
evident (Figures 5A–C). Two-way ANOVA analysis confirmed
no significant effect of genotype at E11.5 or E13.5 (p = 0.35,
0.57 respectively) but did indicate an effect of genotype at E12.5
(p = 0.008). However, post hoc analysis by Tukey’s multiple
comparison test showed no significant difference between the
density of Dll1-expressing cells in PAX77 and control cortex
at any of the six cortical regions examined. This supports the
hypothesis that, while Pax6 is required for the production of a
normal complement of Dll1-expressing cells, its levels do not
affect the numbers produced.
No Apparent Co-expression of Dll1 and
Tbr2 in Developing Cortex
Previous studies have shown that loss of Pax6 causes a loss
of Tbr2+ IPCs (Quinn et al., 2007). We assessed whether
Tbr2+ IPCs express Dll1 RNA since, if they do, our findings in
Pax6 loss-of-function mutants might be explained by a loss of
Tbr2+ IPCs. We combined in situ hybridization for Dll1 with
immunohistochemistry for the IPC marker Tbr2 in E12.5 and
E14.5 cortex (Figure 6). Strong Tbr2 expression was seen in
control embryos at E12.5, spanning the length of the cortex and
largely confined to the subventricular zone (SVZ; Figures 6A,C).
In contrast, Dll1 expression was largely restricted to the VZ. We
FIGURE 5 | Quantitation of Dll1+ cells in PAX77 and control forebrain at
E11.5, E12.5 and E13.5. Bar graphs show the density of Dll1-expressing cells
in specific regions of the cortex in PAX77 transgenic and control embryos at
E11.5 (A), E12.5 (B) and E13.5 (C). No statistically significant changes were
found (analysis of variance, ANOVA). N = 3 embryos of each genotype at
each age.
found no evidence of co-expression of Dll1 and Tbr2 in control
cortex at E12.5 (Figures 6A,C), indicating that a clear majority
of Tbr2+ cells do not express Dll1. As reported previously, the
number of Tbr2-expressing cells was greatly reduced in Pax6−/−
mutants at E12.5 (Figures 6B,D, Quinn et al., 2007). As in
controls, no evidence of co-expression of Dll1 and Tbr2 was
found in the Pax6−/− cortex (Figures 6B,D).
At E14.5, the SVZ constitutes the majority of the cortical
progenitor zone. Dll1 expression remained largely confined
to the narrower VZ region (Figures 6E,G,I,K). As at E12.5,
no co-localization between Dll1 and Tbr2 was observed
(Figures 6G,I,K). Interestingly, however, strong co-localization
ofDll1 and Tbr2 was found in the developing hippocampus (HP)
region at E14.5 (Figure 6E, region between white arrowheads),
indicating that many IPCs in the HP express Dll1, in contrast to
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FIGURE 6 | Expression of Dll1 and Tbr2 in Pax6−/− and control embryos at E12.5 and E14.5. In situ hybridization for Dll1 (magenta) and immunohistochemistry for
Tbr2 (green) at E12.5 (A–F) and E14.5 (G–L). The area delineated by arrowheads in (E,F) indicates the presumptive hippocampal region, where Dll1 and Tbr2 are
co-expressed. Dotted lines indicate the boundary between the VZ and the SVZ. Abbreviations: Ctx, cortex; GE, ganglionic eminences; HP, hippocampus; VZ,
ventricular zone; SVZ, subventricular zone. Scale bars (A,B,E,F): 80 µm; (C,D,G–L): 20 µm.
the neocortex. The presence of Dll1 expression in both the VZ
and SVZ of the developing HP suggests that it is expressed by
both RGCs and IPCs in this region.
In E14.5 Pax6−/− mutant embryos, we found no cells
co-expressing both Dll1 and Tbr2 in either the cortex or
the HP (Figure 6F). As at E12.5, there were many fewer
Tbr2-expressing cells in E14.5 Pax6 −/−mutants than in controls
(Figures 6F,H,J,L).
These findings suggest that the loss of Dll1-expressing cells
in Pax6 loss-of-function mutants is not a manifestation of the
reduction of Tbr2+ IPCs in their cortices. We next considered
whether it might be a consequence of alteredNeurog2 expression.
Overlapping Neurog2 and Dll1 Expression
in Embryonic Cortex
As Pax6 can activate expression of Neurog2 (Scardigli et al.,
2003), and Neurog2 can drive expression of Dll1 (Castro
et al., 2006), we tested the possibility that the changes in
Dll1+ cell density found in Pax6 mutant cortex could be
mediated through Neurog2. We first compared the expression
of Neurog2 and Dll1 in Pax6−/− mutants and controls, to
test whether cortical progenitor cells express both Neurog2
and Dll1. At E12.5, Dll1 and Neurog2 were expressed widely
throughout the progenitor zone of the developing cerebral cortex
in control embryos and many Neurog2/Dll1 double positive
cells were evident (Figures 7A,C) consistent with the possibility
that Pax6 could regulate Dll1 through Neurog2. In Pax6−/−
mutants, there were substantially fewerNeurog2-expressing cells,
especially in the lateral cortex (Figures 7B,D) and, in contrast
to controls, few Dll1 Neurog2 double-positive cells were seen in
FIGURE 7 | Expression of Dll1 and Neurog2 at E12.5 in Pax6−/− and
control telencephalon. In situ hybridizations showing expression of Dll1
(magenta) and Neurog2 (green) in control (A,C) and Pax6−/− (B,D) embryos
at E12.5. Ctx, Cortex. Scale bars: (A) = 100 µm, (C) = 25 µm.
Pax6−/− mutant cortex (Figure 7D), indicating that Pax6−/−
cells that lacked expression of Neurog2 were nonetheless able to
express Dll1.
Dll1 Expression Is Unaffected in
Neurog2−/− Mutant Cortex
Our hypothesis that Pax6 regulates Dll1 expression through
Neurog2 predicts that decreased expression of Neurog2 should
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FIGURE 8 | Dll1 expression in E14.5 Neurog2−/− mutant embryos. In situ hybridization showing Dll1 expression in rostral (A,B), middle (E,F) and caudal (I,J)
regions of E14.5 Neurog2−/− and control embryonic forebrains. Panels (C,G,K) and (D,H,L) show higher power images of regions shown in (A,E,I) and (B,F,J)
respectively.
lead to lower Dll1 expression. However, while Pax6 mutants
showed substantially decreased Neurog2 expression, the effect
on Dll1 was less pronounced (Figure 7). To test directly
whether Neurog2 regulates Dll1 expression, we generated
homozygous Neurog2−/− mutant embryos by intercrossing
heterozygous animals carrying a Neurog2 allele which lacks
Neurog2 activity as a result of the insertion of cre recombinase
coding sequence (Zirlinger et al., 2002). Dll1 expression, as
shown by in situ hybridization, appeared very similar in
E14.5 Neurog2−/− (Figures 8B,D,F,H,J,L) and control embryos
(Figures 8A,C,E,G,I,K), each showing the familiar salt and
pepper staining pattern. Quantitation of Dll1-expressing cell
density in these embryos revealed no statistically significant
differences between Neurog2−/− mutants and controls (data
not shown).
DISCUSSION
Evidence for Interactions Between Pax6
and Dll1
To investigate a possible role for the Notch ligand Dll1 in the
pathway by which Pax6 influences the balance between
proliferation and differentiation of RGC progenitors in
embryonic cortex, we characterized the cortical expression
of Dll1 in detail during key neurogenic stages, both in control
and Pax6−/− mutant embryos. In control embryos at the
earliest stages of neurogenesis (E11.5), Dll1-expressing cells
were significantly more abundant in lateral cortex than medial.
Pax6 is expressed in a high lateral to low medial gradient, so the
presence of more Dll1+ cells in lateral than medial cortex could
suggest an effect of Pax6 levels on Dll1 expression. However,
the medial-lateral difference in Dll1 expression was also seen in
E11.5 Pax6−/− embryos and we found no differences in Dll1+
cell density between Pax6−/− mutant and control embryos at
any position in the E11.5 cortex, arguing against a direct role for
Pax6 levels in setting up the medio-lateral difference in Dll1+
cell density.
At E12.5, the medial-lateral difference in Dll1 expression
was no longer evident. In controls, Dll1+ cell density was
highest in caudomedial cortex, but this was not significantly
different to any other region. In E12.5 Pax6−/− mutants, Dll1
expression was decreased in centrolateral and caudomedial areas
of cortex compared to controls, but unaffected in other regions.
In E13.5 control embryos, caudomedial cortex again showed the
highest density of Dll1+ cells, although this was significantly
higher than only centrolateral and mediolateral areas. In E13.5
Pax6−/− mutants Dll1+ cells were again significantly reduced in
caudomedial cortex, but all other regions showed no significant
change in Dll1+ cells at this stage. Perhaps surprisingly, the
region which showed the most consistent changes in Dll1+ cells
in Pax6 mutants, caudomedial cortex, is also the region where
Pax6 expression levels are lowest.
Dll1 expression was more strongly affected in conditional
Pax6 mutants. Fewer Dll1+ cells were found throughout almost
all regions of the E12.5 cortex in cortex-specific Pax6−/− mutant
embryos, in contrast to constitutive Pax6−/− mutants, in which
only centrolateral and caudomedial cortex showed significant
differences. By E13.5 only caudomedial cortex was affected,
the same region affected in constitutive Pax6−/− embryos at
this stage. A likely explanation for this difference could be the
presence of a mechanism which can compensate for the loss of
Pax6 in all except caudomedial cortex in constitutive Pax6−/−
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mutants but in the E12.5 cKO mutants has not had enough
time after loss of Pax6 for the compensation mechanism to act,
such that the effect of Pax6 loss is seen throughout the cortex.
The principle that conditional mutants may have more severe
phenotypes than constitutive mutants is well established (Rossi
et al., 2015). Increasing the level of Pax6 had no significant
effect on Dll1+ cell numbers, consistent with the finding that
gain of Pax6 function generally has a milder effect on cortical
development than does loss of function (Manuel et al., 2007;
Georgala et al., 2011).
We found large numbers of Dll1+ cells in the VZ
of mouse embryonic cortex, many of them co-expressing
Neurog2, showing that Dll1 is widely expressed in cortical
progenitors. However, we did not find any evidence of Dll1/Tbr2
co-expressing cells, suggesting that Dll1 mRNA expression in
Tbr2+ basal progenitor cells is less common. Dll1 protein has
been detected in Tbr2+ basal progenitors (Nelson et al., 2013),
suggesting that the protein persists after Dll1 mRNA is no longer
expressed. Indeed, Dll1 protein produced by basal progenitors
has been suggested to activate Notch signaling in radial glial
progenitors in the VZ (Mizutani et al., 2007; Yoon et al., 2008;
Nelson et al., 2013).
How Might Pax6 Regulate Dll1 Expression?
We found that loss of Pax6 leads to a decrease in the
number of Dll1+ cells in specific areas of the cortex during
neurogenesis. The absence of a straightforward relationship
between Pax6 function and expression levels and Dll1 expression
suggests that the interaction between these genes is likely to be
indirect. We investigated the possibility that Pax6 could exert its
effect on Dll1 expression indirectly, through the Pax6-regulated
neurogenic transcription factor Neurog2 which can regulate
Dll1 (Castro et al., 2006). In support of this possibility, many
embryonic cortical progenitor cells express both Neurog2 and
Dll1 and expression of both of these genes is decreased in
Pax6−/− mutants. However, no significant difference in Dll1
expression was observed in Neurog2−/− cortex, indicating that
the mechanism is not as simple as this. The continued Dll1
expression in Neurog2−/− mutants suggests that the absence of
Neurog2 can be compensated for. The most likely candidates
to mediate such compensation are the related neurogenic genes
Neurog1 and Ascl1. Neurog1 and Neurog2 are both normally
expressed throughout the cortex, whereas Ascl1 expression is
largely confined to ventral telencephalon (Fode et al., 2000). In
Neurog2−/− mutants, cortical expression ofNeurog1 is decreased
slightly, but Ascl1 expression is strongly upregulated (Fode
et al., 2000). The phenotype of Ascl1−/−; Neurog2−/− double
mutants is much more severe than that of Neurog2−/− single
mutants, indicating that Ascl1 compensates for effects of loss of
Neurog2 function (Fode et al., 2000). Further, Ascl1 has been
shown to be able to directly activate Dll1 expression, acting
on a different enhancer element to that activated by Neurog2
(Castro et al., 2006). Therefore, increased levels of Ascl1 in
Neurog2−/− cortex may maintain expression of Dll1 at normal
levels. However, Ascl1 is also upregulated in Pax6−/− mutant
embryonic cortex (Kroll and O’Leary, 2005), yet significant
regional decreases in Dll1+ cells are observed. This could be
consistent with a direct role for Pax6 in regulating Dll1, that
cannot be compensated for by Ascl1, or may indicate that the
regulation of Dll1 is complex and that other factors are involved.
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